Arkolith/Insider Trading/BTTX/Form 4

Parker Geoffrey M.

DirectorBetter Therapeutics, Inc. (BTTX) · full profile →Form 4 · filed Dec 16, 2021
Net Buying
Open-Market Buys
$99K
Open-Market Sells
$0
Net Open-Market Flow
$99K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 14, 2021Buy(P)20K$4.94$99K53K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-21-048609) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML